Elizabeth J Perlman

  • 11829 Citations
1987 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Pediatric Pathology

Wilms tumors, germ cell tumors, genitourinary development

Certifications and Licenses

Pediatric Pathology
Anatomic Pathology

Training Experience

1990Fellowship, Johns Hopkins Hospital
1990Residency, Johns Hopkins Hospital

Education/Academic qualification

MD, Johns Hopkins University

… → 1984

Research interests

  • Pathology

Fingerprint Dive into the research topics where Elizabeth J Perlman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Wilms Tumor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Kidney Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Germ Cell and Embryonal Neoplasms Medicine & Life Sciences
Histology Medicine & Life Sciences
Comparative Genomic Hybridization Medicine & Life Sciences
Clear Cell Sarcoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2012 2019

Research Output 1987 2019

Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5)

Seibel, N. L., Chi, Y. Y., Perlman, E. J., Tian, J., Sun, J., Anderson, J. R., Ritchey, M. L., Thomas, P. R., Miser, J., Kalapurakal, J. A., Grundy, P. E. & Green, D. M., Jan 1 2019, In : Pediatric Blood and Cancer. 66, 1, e27450.

Research output: Contribution to journalArticle

Clear Cell Sarcoma
Etoposide
Cyclophosphamide
Kidney
Disease-Free Survival

Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study

AREN0321 Study Committee, Sep 1 2019, In : European Journal of Cancer. 118, p. 58-66 9 p.

Research output: Contribution to journalArticle

Wilms Tumor
Doxorubicin
Radiation
Disease-Free Survival
Dactinomycin
2 Citations (Scopus)

A unique subset of low-risk wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A children’s oncology group study

Armstrong, A. E., Gadd, S. L., Huff, V., Gerhard, D. S., Dome, J. S. & Perlman, E. J., Dec 1 2018, In : PloS one. 13, 12, e0208936.

Research output: Contribution to journalArticle

Oncology
Wilms Tumor
Set theory
Tumors
Genes
3 Citations (Scopus)

Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors

Arva, N. C., Bonadio, J., Perlman, E. J. & Cajaiba, M. M., Nov 1 2018, In : Applied Immunohistochemistry and Molecular Morphology. 26, 10, p. 721-726 6 p.

Research output: Contribution to journalArticle

Nerve Growth Factor Receptor
Clear Cell Sarcoma
Pediatrics
Wilms Tumor
Kidney
9 Citations (Scopus)

Outcome and prognostic factors in stage III favorable-Histology wilms tumor: A report from the children’s oncology group study AREN0532

Fernandez, C. V., Mullen, E. A., Chi, Y. Y., Ehrlich, P. F., Perlman, E. J., Kalapurakal, J. A., Khanna, G., Paulino, A. C., Hamilton, T. E., Gow, K. W., Tochner, Z., Hoffer, F. A., Withycombe, J. S., Shamberger, R. C., Kim, Y., Geller, J. I., Anderson, J. R., Grundy, P. E. & Dome, J. S., Jan 20 2018, In : Journal of Clinical Oncology. 36, 3, p. 254-261 8 p.

Research output: Contribution to journalArticle

Wilms Tumor
Loss of Heterozygosity
Histology
Disease-Free Survival
Recurrence